Antidote Health, a NYC-based telehealth provider offering healthcare to households across the United States, raised $22M in Series A funding.
The round was led by iAngels, Group 11, and Flint Capital.
The company intends to use the funds to deepen its market presence, expand its services nationwide and conduct R&D activity, which includes advanced AI screening and clinical decision support system capabilities.
Led by Avihai Sodri, Co-Founder and CEO, Antidote Health is a telehealth company, whose services democratize access, delivering care for the whole family for a single price. It works with businesses of any size, non-profits and individuals to ensure that everyone can have acute, primary and chronic care services, 24/7/365. Antidote Health is available to more than 60 percent of the U.S. population.
FinSMEs
22/03/2022